TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Investor Investigation Over Possible Breaches Of Fiduciary Duties Announced

  • If you are a are current long-term stockholder of shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

May 14, 2013 (Shareholders Foundation) - An investigation on behalf of current long-term stockholders of shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) was announced concerning whether certain Progenics Pharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements. The investigation by a law firm concerns whether certai...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: